Rationale and Application of the Protocol S Anti–Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy
Abstract
Purpose To present the rationale, guidelines, and results of ranibizumab treatment for proliferative diabetic retinopathy (PDR) in Diabetic Retinopathy Clinical Research Network (DRCR.net) Protocol S. Design Post hoc analyses from a randomized clinical trial. Participants Three hundred five participants (394 study eyes) having PDR without prior panretinal photocoagulation (PRP). Methods Intravitreous ranibizumab (0.5 mg) versus PRP for PDR....
Paper Details
Title
Rationale and Application of the Protocol S Anti–Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy
Published Date
Jan 1, 2019
Journal
Volume
126
Issue
1
Pages
87 - 95
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History